greatest antimicrobial activity against K. pneumoniae, C. diversus and Salmonella species; was equal to cefamandole against E. coli, E. agglomerans and P. mirabilis; and was second to cefamandole against Shigella, E. tarda, C. freundii, E. cloacae, E. aerogenes and the pathogenic Neisseriae. Essentially no activity against Serratia and Pseudomonas species was observed. Compared to the other cephalosporins tested, BL-S786 showed poor activity against staphylococci and streptococci. For most species tested, the MBC of the various cephalosporins was the same or within one dilution of their respective MICs. However, for Enterobacter and indole-positive Proteus species, the MBC of BL-S786 and cefamandole was usually >_ 8-fold higher than the MICs. Cefoxitin, on the other hand, showed little MIC/MBC variations against indole-positive Proteus species. Inoculum size had only a small effect on the MICs against most gram-negative species-in some instances> 64-fold increases in MIC resulted by increasing inoculum size from 105 to 107 organisms per ml.
BL-S786 is a new parenterally administered semisynthetic cephalosporin having a broader spectrum of antimicrobial activity as compared with the currently available cephalosporins1 agar with 1 % hemoglobin and 1 % Kellogg's supplement, was prepared incorporating appropriate antibiotic concentrations. The inoculum was made by suspending colonies in MUELLER-HINTON broth, diluted to a concentration of 1 x 101 CFU/ml. Plates were then inoculated by a STEERS' replica-tor1). The MICs were determined after 24 hours of incubation in 5% CO2 at 35'C.
Minimum bactericidal concentrations were determined for 76 organisms from five genera by subculturing 5 Id from each microtiter well. The 5 Id subcultures were transferred to MUELLER-HINTON agar (SMC) and to trypticase soy agar with 4 % rabbit blood (CDC). The subcultures were made with multiple inoculum replicator onto a 150-mm Petri plate. After 48 hours of incubation, the endpoints were read as the lowest concentration yielding no more than 0.1 % survivors (99.9 % kill).
The effect of varying the inoculum concentrations on MIC endpoints was studied on 103 rapid growing facultative anaerobes. Trays were inoculated to achieve final concentrations of 103, 105, and 107 CFU/ml. MICs were interpreted as described above. a. Minimal inhibitory concentration values in jig/ml. and six other cephalosporins. BL-S786 inhibited 44% of the N. gonorrhoeae isolates at the lowest concentration tested (<0.06 jig/ml) and 100% at 2 cg/ml. Cefamandole was most active against the a. Includes Ent. cloacae (4), Ent. aerogenes (4) and Ent. agglonierans (2). Cefoxitin omitted due to lack of antimicrobial activity among Enterobacter species. b. Includes Proteus rettgeri (7), Proteus morganii (2) and one strain of Proteus vulgaris. c. Proteus morganii strains (2) were not tabulated due to inactivity of this antibiotic. Tables 5 and 6 show 76 MIC-MBC comparisons for BL-S786 and six other cephalosporins. Against E. coli, Proteus mirabilis, Klebsiella pneumoniae and S. aureus, 93 % of the cephalosporin MIC results were the same as the MIC or within 1 dilution. BL-S786 had six of fifty-six (10.7%) of the MBC values 4 or more fold higher than the MIC. Cefazolin most often had elevated MBC results, while cefoxitin showed the least MIC-MBC variation.
Results

MIC Comparisons
MIC-MBC Comparisons
A more marked MBC variation was obtained for the cephalosporins among the Enterobacter (7), Proteus morgani (2) and one strain of Proteus vulgaris. b. Includes Enterobacter cloacae (7), Enterobacter aerogenes (6) and Enterobacter agglomerans (2). c. 786=BL-S786, CMD=cefamandole;
CZ=cefazolin; COX=cefoxitin; CLD=cephaloridine; CF= cephalothin; CD= cephradine. species and indole-positive Proteus species tested (Table 6 ). Only BL-S786 and cefamandole had antimicrobial activity against both of these groups. Only 20% and 40% of the MBC results were within a 2-fold dilution of the MIC for BL-S786 and cefamandole respectively. Cefoxitin, active only against indole-positive Protens species, demonstrated a close MIC-MBC correlation.
Inoculum Size MIC Comparisons
The inoculum size effects on MIC results were studied on 103 organisms at 103, 105, and 107 colony forming units/ml (Table 7) . The cephalosporin MICs for the E. coli, K. pneumoniae, and P. mirabilis strains remain constant or only increased two fold by raising the inoculum size from 103 to 105 CFU/ml. However, a marked change was encountered at 107 CFU/ml, where the MIC results increased 2 to greater than 64-fold. BL-S786 had MIC increases 16-fold for E. coli, greater than 64fold for K. pneumoniae, and 8-fold for P. mirabilis. Comparable results were found for cefamandole.
BL-S786, cefamandole, and cephradine were ineffective against K. pneumoniae at 107 CFU/ml. All tested cephalosporins had some activity against indole-positive Proteus species at 103 CFU/ml. However, at 105 CFU/ml inoculum size only cefamandole and cefoxitin remained effective. Only cefoxitin was active at 107 CFU/ml, the median MIC only rose from 8 to 16 hg/ml. BL-S786 and cefamandole were most active against Enterobacter species at 103 and 105 CFU/ml. This inhibitory activity was lost at the highest inoculum size.
All cephalosporins remained active against S. aureus at all three inoculum sizes. Cefoxitin MIC values (median) remained unchanged while other cephalosporins increased 2-to 4-fold.
Additional studies were performed on seven methicillin-resistant S. aureus and eight non-enterococcus group D streptococci (not tabulated). BL-S786 median MIC results at each inoculum size were consistently 8-fold higher for methicillin-resistant strains of S. aureus compared to methicillinsensitive strains in Table 7 . Insignificant inoculum size effects were found among the S. bovis and S. durans strains. Cefazolin and cephaloridine median MICs were unchanged, and the remaining five cephalosporins MICs increased 2-fold from 105 to 107 CFU/ml inoculum size.
Discussion
BL-S786 has been described as a semisynthetic parenteral cephalosporin possessing a wider and more active antimicrobial spectrum currently available agents',". This study confirms that observation and adds additional comparative data with cephradine, cefamandole, and cefoxitin. In comparisons with the latter cephalosporins, BL-S786 antimicrobial activity was most similar to cefamandole though BL-S786 was the most effective cephalosporin tested against K. pneumoniae, C. diversus, and Salmonella species. BL-S786 had an antimicrobial activity against the Enterobacter species, a feature like cefamandole'), and cefuroxime3'". However, cefamandole was approximately 4-fold more active against the Enterobacter species than BL-S786 (Table 2) . Protens rettgeri isolates were inhibited by BL-S786, but the other indole-positive Proteus species and Serratia marcescens were resistant.
Haemophilus influenzae was moderately sensitive to BL-S786. The mean MIC was 4 tag/ml, a value comparable to cefazolin, cephaloridine and cephradine. Cefamandole was the most active cephalosporin against beta lactamase producing and deficient Haemophilus species confirming previous studies',"
BL-S786 MICs for the gonococcus had a bimodal distribution with all isolates inhibited by 2 /cg/ ml. The lowest mode was at < 0.06 pg/ml, the second mode at 1 pg/ml. The pattern was identical to that of cephalothin. Cefamandole had the best activity with closely associated modes <0.6 pg/ml and 0.25 pg/mI. BL-S786 was very active against N. meningitidis. All isolates tested were inhibited by 0.25 pg/ml of BL-S786 and no evidence of bimodal MIC distribution was identified. 
